Inflammatory Demyelinating Polyradiculoneuropathy
📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyradiculoneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Phase 2]
Phase 2 clinical trial for TAK-411 in adults with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
A prospective real-world study is investigating the effectiveness of efgartigimod in CIDP and is currently recruiting.
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Tongji NADs Cohort
Tongji Hospital has announced a NADs cohort trial covering multiple autoimmune neurological diseases including multiple sclerosis and relate…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Phase 3]
A Phase 3 clinical trial comparing TAK-881 with HYQVIA in adults with chronic inflammatory demyelinating polyradiculoneuropathy is currently…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
A clinical study evaluating HyQvia (subcutaneous immunoglobulin with hyaluronidase) in adults with chronic inflammatory demyelinating polyra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) [Phase 3]
Phase 3 study of TAK-771 in Japanese participants with CIDP and MMN has posted results and is listed as not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) [Phase 3]
Phase 3 trial of TAK-771 in Japanese participants with CIDP and MMN completed; results posted.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Role of High Frequency Ultrasound in Demyelinating Polyneuropathies
A completed clinical trial investigating high-frequency ultrasound in demyelinating polyneuropathies, focusing on Chronic Inflammatory Demye…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Biomarkers in Autoimmune Disease of Nervous System
A Tongji Hospital clinical trial is recruiting to study biomarkers in autoimmune diseases of the nervous system, including Neuromyelitis Opt…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP [Phase 3]
Phase 3 trial evaluating long-term tolerability and safety of HYQVIA in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); re…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Phase 3]
Phase 3 trial comparing HyQvia and Gammagard Liquid (Kiovig) in adults with CIDP has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy [Phase 2]
Phase 2 trial evaluating long-term safety, tolerability, and efficacy of Rozanolixizumab in chronic inflammatory demyelinating polyradiculon…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy [Phase 2]
Phase 2 trial updating the efficacy, safety, and tolerability of rozanolixizumab in chronic inflammatory demyelinating polyradiculoneuropath…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies [Phase 2]
Phase 2 trial evaluating rituximab for efficacy and safety in refractory CIDP patients with IgG4 autoantibodies has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 [Phase 3]
Phase 3 extension study update for I10E in maintenance treatment of CIDP; terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Efficacy and Safety Study of I10E in Treatment of Patients With CIDP [Phase 3]
Phase 3 trial of I10E in chronic inflammatory demyelinating polyradiculoneuropathy completed with posted results.
-
CLINICAL_TRIALS research · 2018-06-04Clinical Trial Update: Transcriptome Analysis of the Peripheral Blood in CIDP [NA]
ClinicalTrials.gov update for a study analyzing peripheral blood transcriptomes in Chronic Inflammatory Demyelinating Polyradiculoneuropathy…
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. [Phase 3]
This document reports the completion of a Phase 3 trial comparing fingolimod 0.5 mg once daily to placebo in chronic inflammatory demyelinat…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP [Phase 2, Phase 3]
Phase 2/3 trial evaluating three doses of NewGam for chronic inflammatory demyelinating polyradiculoneuropathy has been terminated. The upda…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: MRI in Diagnosing and Monitoring CIDP
A completed clinical trial evaluated the usefulness of magnetic resonance imaging for diagnosing and monitoring chronic inflammatory demyeli…
-
CLINICAL_TRIALS research · 2016-03-29Clinical Trial Update: Processing Integration in Neurological Patients Using fMRI
This clinical trial update highlights a study using fMRI-based processing integration in neurological patients, with conditions including Ac…
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of Avonex (interferon beta-1a) in chronic inflammatory demyelinating polyradiculoneuropathy…